Enhanced Recovery after Surgery (ERAS) Program for Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery with or without HIPEC: A Systematic Review and a Meta-Analysis
Cancers · 17.01.2023 · 15 (3) · 570
DOI: 10.3390/cancers15030570 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 17.01.2023. Verfasst von Manuela Robella und 14 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Surgical Oncology, Candiolo Cancer Institute, FPO-IRCCS, 10060 Torino, Italy. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, The AIRC program.
Abstract (Originalsprache)
Enhanced recovery after surgery (ERAS) program refers to a multimodal intervention to reduce the length of stay and postoperative complications; it has been effective in different kinds of major surgery including colorectal, gynaecologic and gastric cancer surgery. Its impact in terms of safety and efficacy in the treatment of peritoneal surface malignancies is still unclear. A systematic review and a meta-analysis were conducted to evaluate the effect of ERAS after cytoreductive surgery with or without HIPEC for peritoneal metastases. MEDLINE, PubMed, EMBASE, Google Scholar and Cochrane Database were searched from January 2010 and December 2021. Single and double-cohort studies about ERAS application in the treatment of peritoneal cancer were considered. Outcomes included the postoperative length of stay (LOS), postoperative morbidity and mortality rates and the early readmission rate. Twenty-four studies involving 5131 patients were considered, 7 about ERAS in cytoreductive surgery (CRS) + HIPEC and 17 about cytoreductive alone; the case histories of two Italian referral centers in the management of peritoneal cancer were included. ERAS adoption reduced the LOS (−3.17, 95% CrI −4.68 to −1.69 in CRS + HIPEC and −1.65, 95% CrI −2.32 to –1.06 in CRS alone in the meta-analysis including 6 and 17 studies respectively. Non negligible lower postoperative morbidity was also in the meta-analysis including the case histories of two Italian referral centers. Implementation of an ERAS protocol may reduce LOS, postoperative complications after CRS with or without HIPEC compared to conventional recovery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Surgical Oncology, Candiolo Cancer Institute, FPO-IRCCS, 10060 Torino, Italy.
- Advanced Surgical Oncology Unit, Surgical Oncology of the Esophagus and Digestive Tract, Veneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy.
- Center for Biostatistics, Epidemiology and Public Health (C-BEPH), Deptartment of Clinical and Biological Sciences, University of Torino, 10124 Torino, Italy.
- Abdominal Oncology Department, Fondazione Giovanni Pascale, IRCCS, 80131 Naples, Italy.
- Surgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario A. Gemelli-IRCCS, 00168 Rome, Italy.
- SC Chirurgia Generale d'Urgenza ed Oncologica, AOU Policlinico di Modena, 41125 Modena, Italy.
ORCID-Profile: Manuela Robella, Marco Tonello, Paola Berchialla, Veronica Sciannameo, Antonio Sommariva, Andrea Di Giorgio, Roberta Gelmini, Franco Roviello, Piero Vincenzo Lippolis, Shigeki Kusamura
Förderung
- Cancer Research UK
- The AIRC program
Zitieren
APA
Robella, M., Tonello, M., Berchialla, P., Sciannameo, V., Ilari Civit, A. M., Sommariva, A., Sassaroli, C., Di Giorgio, A., Gelmini, R., Ghirardi, V., Roviello, F., Carboni, F., Lippolis, P. V., Kusamura, S., & Vaira, M. (2023). Enhanced Recovery after Surgery (ERAS) Program for Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery with or without HIPEC: A Systematic Review and a Meta-Analysis. Cancers, 15(3), 570. https://doi.org/10.3390/cancers15030570
Vancouver
Robella M, Tonello M, Berchialla P, Sciannameo V, Ilari Civit AM, Sommariva A, et al. Enhanced Recovery after Surgery (ERAS) Program for Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery with or without HIPEC: A Systematic Review and a Meta-Analysis. Cancers. 2023;15(3):570. doi:10.3390/cancers15030570
BibTeX
@article{Robella2023,
author = {Robella, Manuela and Tonello, Marco and Berchialla, Paola and Sciannameo, Veronica and Ilari Civit, Alba Maria and Sommariva, Antonio and Sassaroli, Cinzia and Di Giorgio, Andrea and Gelmini, Roberta and Ghirardi, Valentina and Roviello, Franco and Carboni, Fabio and Lippolis, Piero Vincenzo and Kusamura, Shigeki and Vaira, Marco},
title = {Enhanced Recovery after Surgery (ERAS) Program for Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery with or without HIPEC: A Systematic Review and a Meta-Analysis},
journal = {Cancers},
year = {2023},
volume = {15},
number = {3},
pages = {570},
doi = {10.3390/cancers15030570}
}
EUVIMED